Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-441302·Freebird Partners LP
Schedule 13G ownership disclosure
ERNEXA THERAPEUTICS INC
Common Stock, par value $0.005 per share · CUSIP: 114082407
Event date: 2026-08-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Freebird Partners LP
Shares: 119,015 · Class: 7.0%
- Freebird Investments LLC
Shares: 119,015 · Class: 7.0%
- Curtis Huff
Shares: 119,015 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-441302
- Form type
- SCHEDULE 13G/A
- Filer
- Freebird Partners LP
- CIK
- CIK 1955231
- Filed
- Oct 30, 2026
- Reporting period
- Aug 05, 2026
- Description
- Schedule 13G beneficial ownership